Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-021111
Filing Date
2024-12-23
Accepted
2024-12-23 15:30:22
Documents
2
Period of Report
2024-12-17

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2114
2 POWER OF ATTORNEY exhibit24-1.htm EX-24.1 476924
  Complete submission text file 0001062993-24-021111.txt   480717
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Issuer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIREO GROWTH INC. 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address
Macdonald Tyson (Reporting) CIK: 0002049701 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-56225 | Film No.: 241573236